Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $4,000 · Income ≤600% FPL (COLI-adjusted) · Covers treatment-related co-pays and co-insurance for prescription drugs, labs, scans and tests
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C83.10 C83.11 C83.12 C83.13 C83.14 C83.15 C83.16 C83.17 C83.18 C83.19 C83.1ADrugs whose J-codes this fund matches. Each links to its billing & coding reference.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 877-557-2672, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Rituxan / biosimilars.
Status shown as of each fund's last verification.
As of July 31, 2026, the Blood Cancer United Mantle Cell Lymphoma fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 877-557-2672.
Up to $4,000. Covers treatment-related co-pays and co-insurance for prescription drugs, labs, scans and tests
Household income must be ≤600% FPL (COLI-adjusted). US resident.
Accepted: commercial, medicare, medicaid, tricare.
The foundation's published processing time is 3–5 business days. Renewal: annual reapplication.